{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:39:37Z","timestamp":1777660777950,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.sapharm.2023.05.017","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T04:12:10Z","timestamp":1685592730000},"page":"1146-1156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-446X","authenticated-orcid":false,"given":"Chee Tao","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew Li","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-6576","authenticated-orcid":false,"given":"Shaun Wen Huey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.05.017_bib2","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.3390\/ijerph18168290","article-title":"Active aging in ASEAN countries: influences from age-friendly environments, lifestyles, and socio-demographic factors","volume":"18","author":"Tiraphat","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.sapharm.2023.05.017_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib4","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1016\/S2666-7568(21)00054-4","article-title":"Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens","volume":"2","author":"Rochon","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.sapharm.2023.05.017_bib5","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1111\/jgs.16743","article-title":"Potentially inappropriate medications are associated with increased healthcare utilization and costs","volume":"68","author":"Clark","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2023.05.017_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jamda.2018.10.026","article-title":"Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis","volume":"20","author":"Kua","year":"2019","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.sapharm.2023.05.017_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","article-title":"Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe","volume":"78","author":"Mid\u00e3o","year":"2018","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.sapharm.2023.05.017_bib9","article-title":"Prevalence and predictors of polypharmacy among Korean elderly","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2023.05.017_bib10","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","article-title":"Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine","volume":"151","author":"Beers","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2023.05.017_bib11","first-page":"2227","article-title":"By the American geriatrics society 2015 Beers criteria update expert panel. American geriatrics society 2015 updated Beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2023.05.017_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.sapharm.2023.05.017_bib13","first-page":"543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch Arzteblatt Int"},{"key":"10.1016\/j.sapharm.2023.05.017_bib14","first-page":"385","article-title":"Defining inappropriate practices in prescribing for elderly people: a national consensus panel","volume":"156","author":"McLeod","year":"1997","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"10.1016\/j.sapharm.2023.05.017_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","article-title":"Potentially inappropriate medications in the elderly: a French consensus panel list","volume":"63","author":"Laroche","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2023.05.017_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237186","article-title":"Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: a cross-sectional study","volume":"15","author":"Lopez-Rodriguez","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2023.05.017_bib17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0895-4356(92)90144-C","article-title":"A method for assessing drug therapy appropriateness","volume":"45","author":"Hanlon","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2023.05.017_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-019-1168-1","article-title":"Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria","volume":"19","author":"Alhawassi","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40520-017-0742-7","article-title":"A prevalence study of potentially inappropriate medications use in hospitalized Pakistani elderly","volume":"30","author":"Mazhar","year":"2018","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.sapharm.2023.05.017_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-016-0285-3","article-title":"Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study","volume":"16","author":"Nam","year":"2016","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000435955","article-title":"Potentially inappropriate prescribing in disabled older patients with chronic diseases: a screening tool of older persons' potentially inappropriate prescriptions versus Beers 2012 criteria","volume":"24","author":"Yang","year":"2015","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.sapharm.2023.05.017_bib22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2147\/CIA.S146009","article-title":"Potentially inappropriate medications in hospitalized older patients: a cross-sectional study using the Beers 2015 criteria versus the 2012 criteria","volume":"12","author":"Zhang","year":"2017","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.sapharm.2023.05.017_bib23","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1111\/bcp.14101","article-title":"Pharmacist services in nursing homes: a systematic review and meta-analysis","volume":"85","author":"Lee","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2023.05.017_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jamda.2020.03.012","article-title":"Association of deprescribing with reduction in mortality and hospitalization: a pragmatic stepped-wedge cluster-randomized controlled trial","volume":"22","author":"Kua","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.sapharm.2023.05.017_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","article-title":"Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria","volume":"74","author":"Motter","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2023.05.017_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ajag.13046","article-title":"A comprehensive look at explicit screening tools for potentially inappropriate medication: a systematic scoping review","volume":"41","author":"Schiavo","year":"2022","journal-title":"Australas J Ageing"},{"key":"10.1016\/j.sapharm.2023.05.017_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jcpt.13273","article-title":"Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department","volume":"46","author":"Zhang","year":"2021","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.sapharm.2023.05.017_bib29","first-page":"60","article-title":"Measuring medicine use: applying ATC\/DDD methodology to real-world data","volume":"9","author":"Hollingworth","year":"2021","journal-title":"Pharm Basel Switz"},{"key":"10.1016\/j.sapharm.2023.05.017_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"},{"key":"10.1016\/j.sapharm.2023.05.017_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med"},{"key":"10.1016\/j.sapharm.2023.05.017_bib32","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2023.05.017_bib33","series-title":"START\/STOPP Criteria Screening Tool","author":"Chau","year":"2015"},{"key":"10.1016\/j.sapharm.2023.05.017_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jrpp.JRPP_19_106","article-title":"Adaptation and validation of the screening tool of older people's prescriptions instrument for the Indonesian population","volume":"9","author":"Fauziyah","year":"2020","journal-title":"J Res Pharm Pract"},{"key":"10.1016\/j.sapharm.2023.05.017_bib35","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/ggi.12890","article-title":"Screening tool for older persons' appropriate prescriptions in Japanese: report of the Japan geriatrics society working group on \u201cguidelines for medical treatment and its safety in the elderly\u201d","volume":"16","author":"Kojima","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.sapharm.2023.05.017_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/0891988719862636","article-title":"Antipsychotic polypharmacy in older adult asian patients with schizophrenia: research on asian psychotropic prescription pattern","volume":"32","author":"Dong","year":"2019","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"10.1016\/j.sapharm.2023.05.017_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpsychires.2020.08.025","article-title":"Incidence, prevalence and prescription patterns of antipsychotic medications use in Asia and US: a cross-nation comparison with common data model","volume":"131","author":"Su","year":"2020","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.sapharm.2023.05.017_bib38","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Arch Med Sci AMS"},{"key":"10.1016\/j.sapharm.2023.05.017_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jppr.1812","article-title":"Type 2 Diabetes mellitus treatment intensification and deintensification in primary care: a retrospective cohort study","volume":"52","author":"Wong","year":"2022","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.sapharm.2023.05.017_bib40","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s40520-020-01736-4","article-title":"Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study","volume":"33","author":"Tao Y","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.sapharm.2023.05.017_bib41","first-page":"655","article-title":"How to use the nominal group and Delphi techniques","volume":"38","author":"McMillan","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2023.05.017_bib42","first-page":"2","article-title":"Criteria of potentially inappropriate medications for older adults in China","volume":"20","author":"Wang","year":"2018","journal-title":"Adverse Drug React J"},{"key":"10.1016\/j.sapharm.2023.05.017_bib43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4082\/kjfm.21.0193","article-title":"Pharmacovigilance and its importance for primary health care professionals","volume":"43","author":"Hamid","year":"2022","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.sapharm.2023.05.017_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.archger.2007.06.006","article-title":"Criteria for high-risk medication use in Thai older patients","volume":"47","author":"Winit-Watjana","year":"2008","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: recommendations based on a methodological systematic review","volume":"31","author":"J\u00fcnger","year":"2017","journal-title":"Palliat Med"},{"key":"10.1016\/j.sapharm.2023.05.017_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221128444","article-title":"Development of a medication review tool for residents in Korean long-term care facilities","volume":"13","author":"Jun","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.sapharm.2023.05.017_bib47","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/14740338.2019.1629416","article-title":"Development of a list of high-risk perioperative medications for the elderly: a Delphi method","volume":"18","author":"Wang","year":"2019","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.sapharm.2023.05.017_bib48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.2020.25473","article-title":"Race and pharmacogenomics\u2014personalized medicine or misguided practice?","volume":"325","author":"Goodman","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2023.05.017_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cts.12771","article-title":"Pharmacogenomics in asian subpopulations and impacts on commonly prescribed medications","volume":"13","author":"Lo","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.sapharm.2023.05.017_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ggi.13331","article-title":"European repository of explicit criteria of potentially inappropriate medications in old age","volume":"18","author":"Ivanova","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.sapharm.2023.05.017_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40266-017-0452-z","article-title":"Potentially inappropriate antihypertensive prescriptions to elderly patients: results of a prospective, observational study","volume":"34","author":"M\u00e1rquez","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2023.05.017_bib52","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejim.2014.07.011","article-title":"Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing","volume":"25","author":"San-Jos\u00e9","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.sapharm.2023.05.017_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319879602","article-title":"The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older people","volume":"10","author":"Chang","year":"2019","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.sapharm.2023.05.017_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40266-013-0146-0","article-title":"FORTA authors\/expert panel members. Consensus validation of the FORTA (Fit fOR the Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly","volume":"31","author":"Kuhn-Thiel","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2023.05.017_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4258\/hir.2010.16.4.231","article-title":"Development of a list of potentially inappropriate drugs for the Korean elderly using the Delphi method","volume":"16","author":"Kim","year":"2010","journal-title":"Healthc Inform Res"},{"key":"10.1016\/j.sapharm.2023.05.017_bib56","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.286.22.2823","article-title":"Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey","volume":"286","author":"Zhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2023.05.017_bib57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijge.2015.05.013","article-title":"Consensus validated list of potentially inappropriate medication for the elderly and their prevalence in South Korea","volume":"9","author":"Kim","year":"2015","journal-title":"Int J Gerontol"},{"key":"10.1016\/j.sapharm.2023.05.017_bib58","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2023.05.017_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation","volume":"46","author":"Gallagher","year":"2008","journal-title":"Int J Clin Pharmacol Therapeut"},{"key":"10.1016\/j.sapharm.2023.05.017_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4235\/agmr.2018.22.3.121","article-title":"Development of a consensus list of potentially inappropriate medications for Korean older adults","volume":"22","author":"Kim","year":"2018","journal-title":"Ann Geriatr Med Res"},{"key":"10.1016\/j.sapharm.2023.05.017_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3143\/geriatrics.51.89","article-title":"Guidance statement on appropriate medical services for the elderly by the study group of the Ministry of Health, Labour and Welfare","volume":"51","year":"2014","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.sapharm.2023.05.017_bib62","article-title":"The Japan-FORTA (Fit fOR the Aged) list: consensus validation of a clinical tool to improve drug therapy in older adults","volume":"91","author":"Pazan","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40266-017-0514-2","article-title":"The EURO-FORTA (fit fOR the aged) list: international consensus validation of a clinical tool for improved drug treatment in older people","volume":"35","author":"Pazan","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2023.05.017_bib64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40266-017-0466-6","article-title":"Appropriateness of oral anticoagulants for the long-term treatment of atrial fibrillation in older people: results of an evidence-based review and international consensus validation process (OAC-FORTA 2016)","volume":"34","author":"Wehling","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2023.05.017_bib65","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/ageing\/afv077","article-title":"Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)","volume":"44","author":"Oelke","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.sapharm.2023.05.017_bib66","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12877-019-1293-x","article-title":"\u201cModified STOPP-START criteria for Sri Lanka\u201d; translating to a resource limited healthcare setting by Delphi consensus","volume":"19","author":"Samaranayake","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02813430902992215","article-title":"The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study","volume":"27","author":"Rognstad","year":"2009","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.sapharm.2023.05.017_bib68","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00508-011-0061-5","article-title":"Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list","volume":"124","author":"Mann","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.sapharm.2023.05.017_bib69","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/pds.3274","article-title":"Using published criteria to develop a list of potentially inappropriate medications for elderly patients in Taiwan","volume":"21","author":"Chang","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2023.05.017_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12877-021-02024-0","article-title":"Development of an explicit tool assessing potentially inappropriate medication use in Hong Kong elder patients","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Geriatr"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123002814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123002814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:31:36Z","timestamp":1761557496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741123002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1551741123002814"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.05.017","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}